Navigation Links
Harris Corporation Leverages CONNECT Solution to Enhance Patient Information Exchange Between DoD and VA
Date:6/28/2010

WASHINGTON, June 28 /PRNewswire-FirstCall/ -- Harris Corporation (NYSE: HRS), as a subcontractor to Evolvent Technologies, Inc., is helping to improve the quality of military patient care provided by enhancing the capabilities of the Bidirectional Health Information Exchange (BHIE) interface.  The exchange is a health enterprise integration capability employed by the Department of Defense (DoD) and the Department of Veterans Affairs (VA) to securely share patient information between agencies.

One important, new feature is the first-time ability to transfer medical imagery and associated studies over the exchange, along with artifacts from the DoD's global Healthcare Artifact and Image Management Solution system.  The term "artifacts" refers to any type of captured image other than diagnostic medical imagery.  This includes electronic scans of paper medical records, photographs and handwritten clinician notes, as well as electronic attachments from files or images and other documents related to patient care.

"Harris is committed to delivering enterprise solutions to improve the quality and efficiency of care delivered to our service men and women," said Jim Traficant, vice president and general manager, Harris Healthcare Solutions.  "As service members move between the DoD and the VA systems, their healthcare information will move with them assuring better care and improved patient outcomes.  Deployment of these enterprise integration capabilities supports President Obama's objective mandate for virtual, integration of the Military Health System and Veterans Affairs electronic health records."

Harris is leveraging its open-source CONNECT solution to modernize the BHIE and standardize its data exchange models as part of the BHIE Functional System Enhancement program.  The open-source CONNECT software enables healthcare organizations to participate in the Nationwide Health Information Network for efficient and secure patient information exchange.

Harris Healthcare Solutions provides secure enterprise intelligence solutions and services for government and commercial customers – including systems integration, intelligent infrastructure, advanced visualization and display, enterprise digital content management and IT solutions.  A leader in federal healthcare IT integration, Harris products, systems and services improve healthcare outcomes by assuring that critical medical and benefits information is delivered with security and privacy to the right person, on the right device, at the point of care.

About Harris Corporation

Harris is an international communications and information technology company serving government and commercial markets worldwide.  Headquartered in Melbourne, Florida, the company has approximately $5 billion of annual revenue and more than 15,000 employees — including nearly 7,000 engineers and scientists.  Harris is dedicated to developing best-in-class assured communications® products, systems, and services.  Additional information about Harris Corporation is available at www.harris.com.


'/>"/>
SOURCE Harris Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
2. Harris Corporation Teams with Cancer Treatment Services International to Advance Oncology Treatment
3. Pinstripe Welcomes Carrie Harris-Muller To Board
4. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
5. CEL-SCI Corporation Releases Letter to Shareholders
6. Alfacell Corporation to Present at UBS Global Life Sciences Conference
7. Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic
8. Genaera Corporation Presents Preclinical Trodusquemine (MSI-1436) Data at the North American Association for the Study of Obesity Annual Meeting
9. Genaera Corporation Presents Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting
10. The Quigley Corporation Reports Third Quarter Results, Increases Investment in Pharmaceutical R&D for Diabetic Neuropathy
11. Genaera Corporation Provides Highlights of Positive Phase 1 Trodusquemine (MSI-1436) Data from the North American Association for the Study of Obesity Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):